Article Text
Editorial
Digoxin for rheumatic heart disease: a cautious future for a drug from the past?
Statistics from Altmetric.com
Footnotes
Contributors BRN and AZB participated in literature review, analysis of the original manuscript, drafting and reviewing the final version of the editorial.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.
Data sharing statement The data analytic methods and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure, from the corresponding author on reasonable request.
Linked Articles
- Valvular heart disease